Mitotic G2/M transition checkpoint

pathway activity — cross-omics
GO:0044818Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Mitotic G2/M transition checkpoint pathway is significantly associated with the RNA expression of multiple genes, with the LSCC cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are MCM4, ATAD5, and REXO5, each associated with the pathway in up to 4 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Mitotic G2/M transition checkpoint activity versus MCM4 in LSCC (Pearson r = 0.28).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LSCCMCM4 →+0.793+0.691.001.00234
LSCCATAD5 →+0.727+0.644.003.00134
LSCCREXO5 →+0.559+0.658.003.00334
BRCARFC3 →+0.632+0.411.001.00734
BRCATMBIM1 →-0.536-0.415.002.00734
LUADRNU6-216P →+0.484+0.588.004.00633
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0044818 vs MCM4 — LSCC

Per-sample scatter of Mitotic G2/M transition checkpoint activity vs MCM4 in LSCC.

Explore this scatter interactively →

Exploration